Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (10) | Back to Search
HPS-186 - Prognostic analysis of survival in patients with advanced non-small cell lung cancer treated with antineoplastic agents
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: HPS-186
- By: HAO, Zhiying (Shanxi Cancer Hospital, China)
- Co-author(s): Zhiying Hao (Shanxi Cancer Hospital, Taiyuan, China)
Keao Zheng (Shanxi Cancer Hospital, Taiyuan, China) - Abstract:
Introduction: To develop and validate a prediction model for the 5-year survival rate of patients with advanced non-small cell lung cancer (NSCLC) by integrating the basic information and clinical data of patients.
Methods: A total of 313 patients with advanced NSCLC from the Cancer Hospital of Shanxi Medical University were randomly assigned.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025